Fotemustine
福莫司汀
Report date: 2022/04/19 14:27:33
NME
Base Information
Drug NameFotemustine
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesLes Laboratoires Servier
Inactive CompaniesInstitut CurieInstitut Regional Du Cancer De Montpellier
Active Indications
Inactive Indications